Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LAB NASDAQ:PRE NYSE:SENS NASDAQ:TER On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$1.31$1.25$0.92▼$2.32$497.57M1.321.36 million shs2.02 million shsPREPrenetics Global$7.65-1.3%$8.07$3.09▼$11.99$100.63M0.1545,442 shs28,322 shsSENSSenseonics$0.48+1.9%$0.51$0.25▼$1.40$309.71M0.888.34 million shs3.02 million shsTERTeradyne$114.01+2.1%$94.12$65.77▼$144.16$17.76B1.724.81 million shs5.22 million shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools+2.75%+0.77%-0.76%+22.43%-17.61%PREPrenetics Global-3.13%-2.88%-1.77%+33.62%+41.94%SENSSenseonics+1.50%-6.39%-4.73%-18.29%+22.93%TERTeradyne+6.64%+4.40%+15.02%+32.47%-8.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLABStandard BioTools1.7377 of 5 stars2.03.00.00.02.03.30.6PREPrenetics Global2.5461 of 5 stars2.55.00.00.03.30.01.3SENSSenseonics2.2571 of 5 stars3.82.00.00.02.80.00.6TERTeradyne4.6464 of 5 stars2.33.01.73.44.12.52.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABStandard BioTools 2.00Hold$1.5518.32% UpsidePREPrenetics Global 3.00Buy$9.0017.65% UpsideSENSSenseonics 3.50Strong Buy$1.55221.44% UpsideTERTeradyne 2.56Moderate Buy$114.440.37% UpsideCurrent Analyst Ratings BreakdownLatest TER, LAB, PRE, and SENS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/13/2025LABStandard BioToolsCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold8/13/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$1.557/31/2025TERTeradyneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$120.00 ➝ $130.007/31/2025TERTeradyneStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$85.00 ➝ $100.007/31/2025TERTeradyneMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeUnderweight ➝ Equal Weight$74.00 ➝ $100.007/30/2025TERTeradyneThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$85.007/30/2025TERTeradyneCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy7/21/2025TERTeradyneUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$110.00 ➝ $120.007/17/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025SENSSenseonicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025TERTeradyneJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Neutral$88.00 ➝ $102.00(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABStandard BioTools$174.43M2.85N/AN/A$1.27 per share1.03PREPrenetics Global$30.62M3.24N/AN/A$13.20 per share0.58SENSSenseonics$25.47M12.39N/AN/A$0.07 per share6.89TERTeradyne$2.82B6.43$4.04 per share28.19$17.84 per share6.39Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABStandard BioTools-$138.88M-$0.35N/AN/AN/A-69.08%-19.72%-14.90%10/29/2025 (Estimated)PREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%10/6/2025 (Estimated)SENSSenseonics-$60.39M-$0.10N/AN/AN/A-362.30%-842.25%-67.99%N/ATERTeradyne$542.37M$2.8939.4522.352.3416.59%18.16%13.80%10/22/2025 (Estimated)Latest TER, LAB, PRE, and SENS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025TERTeradyne$0.54$0.57+$0.03$0.49$649.02 million$651.80 million6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABStandard BioToolsN/AN/AN/AN/AN/APREPrenetics GlobalN/AN/AN/AN/AN/ASENSSenseonicsN/AN/AN/AN/AN/ATERTeradyne$0.480.42%N/A16.61%1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABStandard BioToolsN/A6.125.37PREPrenetics GlobalN/A2.071.89SENSSenseonics59.172.472.38TERTeradyneN/A2.351.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABStandard BioTools53.74%PREPrenetics Global25.01%SENSSenseonics12.36%TERTeradyne99.77%Insider OwnershipCompanyInsider OwnershipLABStandard BioTools23.16%PREPrenetics Global7.80%SENSSenseonics4.30%TERTeradyne0.16%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABStandard BioTools620379.82 million291.86 millionOptionablePREPrenetics Global112.98 million11.97 millionNot OptionableSENSSenseonics90654.22 million573.90 millionN/ATERTeradyne6,500159.07 million158.82 millionOptionableTER, LAB, PRE, and SENS HeadlinesRecent News About These Companies5 Insightful Analyst Questions From Teradyne’s Q2 Earnings CallAugust 13 at 11:59 AM | uk.finance.yahoo.comTeradyne, Inc. (NASDAQ:TER) Shares Sold by Arrowpoint Investment Partners Singapore Pte. Ltd.August 13 at 6:45 AM | marketbeat.com8,916 Shares in Teradyne, Inc. (NASDAQ:TER) Acquired by Aigen Investment Management LPAugust 13 at 5:08 AM | marketbeat.comVirtu Financial LLC Purchases New Shares in Teradyne, Inc. (NASDAQ:TER)August 13 at 4:58 AM | marketbeat.comNational Bank of Canada FI Increases Stake in Teradyne, Inc. (NASDAQ:TER)August 13 at 4:15 AM | marketbeat.comDeutsche Bank AG Acquires 175,534 Shares of Teradyne, Inc. (NASDAQ:TER)August 13 at 3:44 AM | marketbeat.comTeradyne Stock Surges Following AI-Driven Gains and Magnum 7H LaunchAugust 13 at 2:17 AM | insidermonkey.comTeradyne Stock Surges Following AI-Driven Gains and Magnum 7H LaunchAugust 13 at 2:58 AM | msn.comHoneywell and Teradyne Robotics Team Up to Automate Material Transport and Scale AutomationAugust 12 at 4:07 PM | automationworld.comAAre Wall Street Analysts Bullish on Teradyne Stock?August 12 at 4:07 PM | msn.comFirst American Trust FSB Cuts Stake in Teradyne, Inc. (NASDAQ:TER)August 12 at 6:25 AM | marketbeat.comCCM Investment Group LLC Invests $538,000 in Teradyne, Inc. (NASDAQ:TER)August 12 at 6:24 AM | marketbeat.comTeradyne, Inc. (NASDAQ:TER) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.August 12 at 4:34 AM | marketbeat.comWhy Teradyne (TER) International Revenue Trends Deserve Your AttentionAugust 11 at 10:16 AM | zacks.comCitigroup Inc. Sells 245,309 Shares of Teradyne, Inc. (NASDAQ:TER)August 11 at 4:52 AM | marketbeat.comASR Vermogensbeheer N.V. Takes Position in Teradyne, Inc. (NASDAQ:TER)August 11 at 4:43 AM | marketbeat.comVanguard Group Inc. Acquires 516,332 Shares of Teradyne, Inc. (NASDAQ:TER)August 11 at 4:42 AM | marketbeat.comUS Bancorp DE Trims Holdings in Teradyne, Inc. (NASDAQ:TER)August 10 at 3:51 AM | marketbeat.comLPL Financial LLC Increases Holdings in Teradyne, Inc. (NASDAQ:TER)August 10 at 3:28 AM | marketbeat.comHeadlands Technologies LLC Has $917,000 Stock Position in Teradyne, Inc. (NASDAQ:TER)August 9, 2025 | marketbeat.comBank of Nova Scotia Sells 232,627 Shares of Teradyne, Inc. (NASDAQ:TER)August 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 2025This Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025These 3 Rare Earth Stocks Are Surging Alongside MP MaterialsBy Leo Miller | July 19, 20253 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025TER, LAB, PRE, and SENS Company DescriptionsStandard BioTools NASDAQ:LAB$1.31 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.32 +0.00 (+0.38%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.Prenetics Global NASDAQ:PRE$7.65 -0.10 (-1.29%) Closing price 04:00 PM EasternExtended Trading$7.82 +0.17 (+2.16%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Senseonics NYSE:SENS$0.48 +0.01 (+1.86%) Closing price 04:00 PM EasternExtended Trading$0.48 -0.01 (-1.08%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.Teradyne NASDAQ:TER$114.01 +2.38 (+2.13%) Closing price 04:00 PM EasternExtended Trading$113.61 -0.40 (-0.35%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Teradyne, Inc. designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications. This segment also provides FLEX test platform systems; J750 test system to address the volume semiconductor devices, including microcontrollers; Magnum platform that tests memory devices, such as flash memory and DRAM; and ETS platform for semiconductor manufacturers, and assembly and test subcontractors in the analog/mixed signal markets. It serves integrated device manufacturers that integrate the fabrication of silicon wafers into their business; fabless companies that outsource the manufacturing of silicon wafers; foundries; and semiconductor assembly and test providers. The System Test segment offers defense/aerospace test instrumentation and systems; storage and system level test systems; and circuit-board test and inspection systems. The Wireless Test segment provides wireless test solutions for silicon validation, wireless module manufacturing, and wireless end device manufacturing under the LitePoint brand. This segment also offers IQxel-MX and IQxel-MW7G series products for edge measurement performance in the manufacturing of connectivity products; IQxstream-5G and IQgig-5G family products to support 4G and 5G technologies; and IQgig-UWB+ for certification and manufacturing test support for ultra wideband products. The Robotics segment provides collaborative robotic arms, autonomous mobile robots, and advanced robotic control software for manufacturing, logistics, and industrial customers. The company was incorporated in 1960 and is headquartered in North Reading, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests 5 Stocks Insiders Are Selling That Analysts Say Buy CoreWeave Pulls Back Into a Screaming Buy Amazon’s Bears Have Raised the White Flag—Get Excited Rocket Lab Scores Analyst Upgrades, Finalizes Geost Takeover Why BigBear.ai Stock's Dip on Earnings Can Be an Opportunity Catalysts Align: Archer Beats Estimates, Delivers Aircraft to UAE Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.